Godrej Industries Ltd (GODREJIND) Q1 FY27 Results Analysis: Revenue Grows 22%, PAT Declines 19%

Cofacto Research Updated August 14, 2026 2 min read
Neutral

Godrej Industries Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 5,448.09 Cr (+22.16% YoY) and PAT growth of -18.57% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 13, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 5,448.09 Cr (+22.16% YoY)
PAT (Q1)Rs. 523.36 Cr (-18.57% YoY)
EBITDA margin12.82% (+185 bps YoY)
EPS (Q1)Rs. 8.44 (-18.61% YoY)
Market capRs. 42,295.02 Cr
CMPRs. 1,255.60

Quarter Snapshot

Revenue grew 22% YoY and EBITDA margin expanded 185 bps, driven by a strong Chemicals recovery (PBIT +86%). However, PAT attributable to owners declined 19% due to a 29% surge in finance costs and lower other income. Balance sheet leverage increased. A mixed quarter with solid operational performance but earnings headwinds from rising interest costs.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 22.16% YoY to Rs.5,448.09 Cr.
  • EBITDA margin expanded 185 bps YoY to 12.82%, the strongest Q1 EBITDA margin in visible trailing data.
  • Chemicals segment PBIT nearly doubled (+85.66% YoY) with margin expanding to 13.72% from 9.72%.
  • Derived EBITDA grew 42.78% YoY to Rs.698.50 Cr, indicating operating leverage.

Risk Factors

  • PAT attributable to owners declined 18.57% YoY to Rs.284.36 Cr.
  • Finance costs surged 29.30% YoY to Rs.745.14 Cr, and gross debt-to-equity rose to 2.38x.
  • Other Income dropped 27.55% YoY, contributing to earnings decline.
  • Veg Oils margin compressed 270 bps YoY to 11.56% due to commodity pass-through.
  • Dairy segment remained loss-making with PBIT of -Rs.1.90 Cr.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now